A human monoclonal antibody targeting alpha-Gal ameliorates experimental cutaneous leishmaniasis. Cho H, Paun A, Seo Y, Lee SH, et al. J Infect Dis 2025 Jul 1:jiaf350. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cho H, Paun A, Seo Y, Lee SH, et al. A human monoclonal antibody targeting alpha-Gal ameliorates experimental cutaneous leishmaniasis. J Infect Dis 2025 Jul 1:jiaf350. doi: 10.1093.
PMID: 40591906